New Members Have Joined HD-PLC Alliance to Accelerate the HD-PLC Advancement Towards a Global Power Line Communication Standard
3.8.2021 16:00:00 EEST | Business Wire | Press release
HD-PLC Alliance (*1), Fukuoka, Japan (Alliance) announced that 4 newcomers has joined the alliance this year. The member list on Alliance website was updated as follows;
MicroChip Technology as Supporter since July, is a leading provider of smart, connected and secure embedded control solutions. Its easy-to-use development tools and comprehensive product portfolio enable customers to create optimal designs which reduce risk while lowering total system cost and time to market. The company’s solutions serve more than 120,000 customers across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. Microchip is headquartered in Chandler, Arizona.
LVX Global, as Supporter since May, is an international technology solutions business that identifies, designs, delivers and manages high value, scalable, replicable social outcomes at the intersection of technology, engineering, and human behavioural science.
Helvetia, as Standard since May, is a Japanese company. Based on long-time accumulated, experienced knowledge of the industrial field that requires reliability, Helvetia supports enthusiastically to solve customers’ problems of hardware and software design.
And Shanghai Clouder Semiconductor, as Supporter since April, founded in July 2012, is a fabless design house. The company’s main product CR600 uses HD-PLC Inside Plus technology. CR600 application field is mainly two-wire door-phone System.
Since its establishment in 2007, the Alliance has carried out global activities in Europe, U.S.A, Asia to expand and disseminate HD-PLC (*2) and to ensure interoperability. As a result, the global IEEE Standard 1901 (*3) was approved in 2010, adopting HD-PLC as a core technology. "The IEEE 1901 standard is the FIRST standard that converted scattered initiatives into a profitable industry offering assurance of interoperability to users” said Jean-Philippe Faure, IEEE 1901 Working Group Chair. IEEE 1901 has updated as “IEEE 1901 std-2020” early this year to move forward to the 2nd decade.
Comments from these members;
“Microchip is delighted to join the HD-PLC Alliance and extend our product offering with innovative, open-standard and scalable technology solutions. As a leading supplier of total system solutions for smart, connected and secure technology, we look forward to the HD-PLC as a terrific addition to our offering of wired solutions, particularly in the areas of Internet of Things (IoT) and smart energy applications," said Andres Munoz, Marketing Manager, Smart Energy Communications at MicroChip.
“LVX Global is excited to join the HD-PLC Alliance, our participation is part of our belief in building an international global power line communication standard, and is core to having open and reliable communications as well as sustainable systems for the management of smart cities“ said Matthias Lürkens, GM Connectivity & Standardization for LVX Global.
“Helvetia is excited to join the HD-PLC Alliance. Our participation aims to make smart city management a sustainable system using HD-PLC.” said Katsushi Mori, CEO of Helvetia.
“Panasonic's HD-PLC technology provides a cost-effective, safe and reliable simple way for the two-wire door-phone system. We are very happy to be able to introduce HD-PLC Inside Plus technology into the Clouder’s CR600 chip to help customers achieve better efficiency and stability in use. It is a great honor to join the HD-PLC alliance, wish the alliance better and better.” said Lee Jichuan, CEO of Shanghai Clouder Semiconductor.
The Alliance held HD-PLC global web seminars or “Webinars” jointly with IEEE SA in March and June, and explores to organize next Webinar this fall.
The Alliance welcomes other new member to together expand the use of HD-PLC across various use cases in countries around the world.
Note:
*1: The unincorporated association founded by Panasonic Corporation in 2017, which aims to expand and increase the use of HD-PLC and ensure interoperability between equipment with built-in HD-PLC.
*2: HD-PLC™ or HD-PLC™ mark is a registered trademark or trademark of Panasonic Corporation in Japan and in other countries.
*3: IEEE: Institute of Electrical and Electronics Engineers, U.S.A. The global standard on high-speed Power Line Communication that adopted HD-PLC as core technology in 2010. The latest revision, IEEE 1901 std-2020, has been published in January 2021.
https://standards.ieee.org/standard/1901-2020.html
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210803005413/en/
Contact information
HD-PLC Alliance
Ryoji Kido,
E-mail: info@hd-plc.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
